Tysabri Lawsuit

A Tysabri lawsuit is a personal injury case that seek to hold Biogen Idec and Élan financially and legally responsible for potential injuries sustained by Tysabri users.  A Tysabri lawsuit alleges that serious health complications and deaths are the result of taking this medication to treat multiple sclerosis (MS) and Crohn’s disease.

Approved by the Food and Drug Administration (FDA) in 2004 and first sold under the name Antegren, Tysabri is administered via infusion every 28 days.  To date, Tysabri is one of the most popular drug therapies for MS.  Clinical studies indicate that Tysabri may largely suppress the debilitating symptoms of MS or, in the best cases, send the condition into full remission.

Though potent and effective, Tysabri may cause patients to develop a serious viral brain disease known as progressive multifocal leukoencephalopathy (PML).  In fact, Tysabri’s current packaging notes that approximately 1.16 of every 1,000 Tysabri patients will develop PML.  Roughly five percent of those diagnosed with PML will live longer than twelve months following their diagnosis. PML is the primary subject of a Tysabri lawsuit.

Currently, more than 30 patients with a history of taking Tysabri have been diagnosed with PML, and 20 have died due to severe Tysabri side effects.

Tysabri Recall and Label Change

Within one year of Tysabri’s FDA approval, two cases of PML related to Tysabri use were reported to the FDA.  Biogen Idec and Élan voluntarily pulled Tysabri from the U.S. market.  In 2006, Tysabri was reintroduced to the U.S. with stricter protocols for administering the drug and monitoring patients taking the medication.  Among the new requirements was that Tysabri patients participate in the TYSABRI Outreach: Unified Commitment to Health (TOUCH) Prescribing Program, which is dedicated to looking after patients’ health while they are on a course of this medication.

In 2009, Biogen Idec and Élan updated the warning labels on Tysabri to highlight its severe, life-threatening side effects, while also alerting patients that those who take this medication for longer periods of time will have an increased risk of developing serious health complications.  In fact, the Tysabri FDA warning notes that, on average, Tysabri patients diagnosed with PML have undergone 25 infusion sessions.

Tysabri Lawsuit For Compensation of Tysabri PML Victims

Those diagnosed with a serious Tysabri side effect and families who have lost a loved one as a result of Tysabri complications may have a strong defective drug Tysabri lawsuit against the makers of this medication.  Injured parties are encouraged to learn more about Tysabri lawsuits and their legal rights, as well as get their Tysabri lawsuit started at no upfront cost to them by attending a complimentary, risk-free initial consultation with a skilled Tysabri lawsuit attorney.

If you or a loved one has used Tysabri and has been diagnosed with PML, you should contact our Tysabri lawsuit attorneys immediately for a free and confidential case review.  You may be entitled to compensation through a Tysabri wrongful death lawsuit or Tysabri settlement, and we can help.